ADVFN US – Market Content Editor
-
Kohl’s shares slide as weak sales outlook outweighs earnings beat
Kohl’s Corporation (NYSE:KSS) shares fell in premarket trading on Tuesday after the retailer reported fourth-quarter earnings that exceeded expectations but delivered slightly weaker revenue and issued fiscal 2026 guidance below analyst forecasts. The stock dropped about 10%. The company posted adjusted earnings per share of $1.07 for the fourth quarter, surpassing the analyst consensus estimate…
-
CRISPR Therapeutics shares drop after announcing convertible notes sale
CRISPR Therapeutics AG (NASDAQ:CRSP) shares declined 6.75% on Tuesday after the company revealed plans to raise $350 million through a convertible senior notes offering. The gene-editing firm said it plans to issue convertible senior notes due in 2031 through a private placement aimed at qualified institutional buyers under Rule 144A of the Securities Act. The…
-
Atlas Energy Solutions reaches power equipment agreement with Caterpillar
Atlas Energy Solutions Inc. (NYSE:AESI) announced it has signed a Global Framework Agreement with Caterpillar Inc. (NYSE:CAT) covering roughly 1.4 gigawatts of power generation equipment, with orders expected to be placed between 2027 and 2029. The deal carries total purchase commitments of about $840 million over the contract period. Atlas said that with the successful…
-
Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study
Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular Dystrophy Association Clinical & Scientific Conference 2026 held in Orlando, Florida. The research utilized a humanized Duchenne muscular dystrophy (DMD) mouse model designed to mirror the muscle degeneration seen in patients with the disease. Treatment with PBGENE-DMD resulted in…
-
MiNK Therapeutics shares jump 80% after C-Further partnership announcement
MiNK Therapeutics (NASDAQ:INKT) shares climbed about 80% on Tuesday after the company revealed a collaboration with C-Further aimed at developing a PRAME-targeted iNKT cell therapy for pediatric cancers. Under the agreement, the clinical-stage biopharmaceutical company will receive around $1.1 million in non-dilutive funding to help support IND-enabling development of its PRAME-TCR-iNKT program. The deal also…
-
Apple now produces about 25% of iPhones in India as it reduces reliance on China, Bloomberg reports
Apple Inc (NASDAQ:AAPL) has significantly increased iPhone manufacturing in India, highlighting the company’s efforts to diversify production away from China amid ongoing trade tensions and tariff concerns, according to a Bloomberg report published Tuesday. Apple assembled approximately 55 million iPhones in India in 2025, representing an increase of about 53% compared with roughly 36 million…
-
Amazon convenes engineers to review AI-related service outages – FT
Amazon (NASDAQ:AMZN) has summoned a large group of engineers to a meeting on Tuesday to investigate a series of service disruptions tied to artificial intelligence, the Financial Times reported. According to a briefing document for the meeting reviewed by the FT, the company has observed a “trend of incidents” in recent months, characterized by a…
-
AT&T plans over $250 billion investment in U.S. network infrastructure by 2030
AT&T Inc. (NYSE:T) said it plans to invest more than $250 billion over the next five years to expand its fiber and wireless network infrastructure across the United States through 2030, according to a company announcement. The telecommunications group stated that the investment will be directed toward expanding fiber networks, 5G home internet, wireless services…
-
Uranium Energy shares rise nearly 4% after strong uranium sales pricing
Uranium Energy Corp (AMEX:UEC) reported fiscal second-quarter 2026 results on Tuesday, posting adjusted earnings per share of -$0.03, in line with analyst expectations. Revenue for the quarter ended January 31, 2026 totaled $20.2 million. The company’s shares climbed 3.98% in pre-market trading following the announcement. UEC’s strategy of selling uranium without hedging enabled the company…
-
Canterbury Park posts Q4 loss while revenue tops expectations
Canterbury Park Holding Corporation (NASDAQ:CPHC) reported a fourth-quarter loss of -$0.08 per share on Monday, while revenue reached $12.45 million, representing a 3.9% increase from $12.0 million recorded in the same period a year earlier. The company’s shares were unchanged in after-hours trading following the release of the results. The rise in fourth-quarter revenue was…